
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA.
San Ramon, Calif., and Xiamen, China, March 13, 2017 — BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced commercialization and the first clinical use of its closed-chest Revivent TC™ System in the People’s Republic of China. The Less Invasive Ventricular Enhancement™ or LIVE™ procedure was performed by interventional cardiologist Prof. Yan Wang, M.D., Director of the Xiamen Cardiovascular Hospital and his structural heart team in Xiamen, China.
San Ramon, Calif., February 6, 2017 — BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced that InEk, the German Institute for the Hospital Remuneration System, has awarded NUB Status 1 for the Revivent TC™ TransCatheter Ventricular Enhancement System.
San Ramon, Calif., and Hamburg, Germany, December 19, 2016 — BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced the first closed-chest Revivent TCTM TransCatheter Ventricular Enhancement System procedure in Germany since receiving CE mark certification. The Less Invasive Ventricular EnhancementTM or LIVETM procedure was performed by interventional cardiologists Dr. Christian Frerker, MD and Dr. Tobias Schmidt, MD and by cardiothoracic surgeon Dr. Ralf Bader, MD at Asklepios Klinik St. Georg in Hamburg, Germany. The St. Georg Heart team is led by Prof. Dr. Karl-Heinz Kuck, who is also the Chairman of the Department of Cardiology and Electrophysiology.
San Ramon, Calif., and Nieuwegein, The Netherlands, November 21, 2016 — BioVentrix, Inc. a pioneer of technologies and procedures for less invasive treatment of heart failure (HF), today announced the first clinical use in the Netherlands of its closed-chest Revivent TC™ TransCatheter Ventricular Enhancement System. The Less Invasive Ventricular Enhancement™ or LIVE™ procedure was performed by cardiothoracic surgeon Dr. Patrick Klein, MD and by interventional cardiologist Dr. Pierfrancesco Agostoni, MD at the St. Antonius Hospital in Nieuwegein, The Netherlands.
SAN RAMON, Calif., October 4, 2016 — BioVentrix, Inc., a pioneer of technologies and procedures for less-invasive treatment of heart failure, today announced that current Board member Steven Healy has been appointed to the position of Chairman of the Board of Directors.
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA.
SAN RAMON, Calif. – Febyary 8, 2021 BioVentrix, Inc., a privately...
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site. To find out more, including how to change your settings, View our Cookie Policy